VIDEOS
03:57
Boehringer Ingelheim’s Telmisartan is the ONLY ARB that is INDICATED* to reduce both CV morbidity and mortality for high-risk patients
01:02
Telmisartan as initial dose for hypertension
02:19
Cost Effectiveness – Price Comparison of Telmisartan (Micardis®) & Telmisartan + Amlodipine besilate (Twynsta®)
04:16
Start with Boehringer Ingelheim’s Telmisartan in mild to moderate hypertensive patients
03:37
Boehringer Ingelheim’s Telmisartan provides renal benefits to high-risk* hypertensive patients
02:58